Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier.

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Abstract Text:

Cathryn S Mellersh,Kathryn T Graves,Bryan McLaughlin,Rosalyn B Ennis,Louise Pettitt,Mark Vaudin,Keith C Barnett,Cathryn S Mellersh,Kathryn T Graves,Bryan McLaughlin,Rosalyn B Ennis,Louise Pettitt,Mark Vaudin,Keith C Barnett,

Primary hereditary cataract (HC) is one of the most common disorders in purebred dogs and is a leading cause of blindness. Boston Terriers suffer from 2 distinct forms of HC which occur at different ages and which are different in their appearance and progression. Early-onset hereditary cataract (EHC) affects dogs within the first few months of life, is always progressive and bilateral, and results in total blindness, whereas late-onset hereditary cataract (LHC) in general affects dogs over the age of 3 and is more variable in its clinical phenotype, age of onset, progression, and the degree to which vision is impaired. A mutation in HSF4 has recently been reported in a small number of Boston Terriers affected with EHC. In this study, we analyzed 22 additional Boston Terriers affected with early-onset cataract to confirm that the HSF4 mutation is causative for this form of cataract in this breed. In addition, we analyzed 40 Boston Terriers that were either clinically clear or affected with LHC for the presence or absence of the HSF4 mutation. By also sequencing HSF4 in dogs affected with LHC, we conclude that HSF4 is not associated with the development of the late-onset form of cataract and that the 2 forms of cataract in this breed are therefore genetically discrete conditions.

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Publishing Authors By Initials

CS Mellersh,KT Graves,B McLaughlin,RB Ennis,L Pettitt,M Vaudin,KC Barnett,CS Mellersh,KT Graves,B McLaughlin,RB Ennis,L Pettitt,M Vaudin,KC Barnett,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The Journal of heredity

VOLUME: 98

Page Numbers: 531-3

Journal Abbreviation: J. Hered.

ISSN: 0022-1503

DAY: 4

MONTH: 07

YEAR: 2007

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375373

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier.

AFFILIATION: Animal Health Trust, Lanwades Park, Newmarket, Suffolk, CB8 7UU, UK. cathryn.mellersh@aht.org.uk

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Hered

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier Related Publications

• 3,4-dichloropropionaniline suppresses normal macrophage function.
• A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.
• A history of research on yeasts 10: foundations of yeast genetics.
• A proposed preoperative grading scheme to assess risk for surgical resection of primary and secondary intraaxial supratentorial brain tumors.
• Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance.
• Behavioral economic approaches to reduce college student drinking.
• Broadening our view of protective antibody responses against HIV.
• Calponin is expressed by subpopulations of connective tissue cells but not olfactory ensheathing cells in the neonatal olfactory mucosa.
• Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?
• Chemical vasectomy of domestic dogs in the Galapagos islands.
• Coronary vessel development is dependent on the type III transforming growth factor beta receptor.
• Electrode placement during stimulus evoked electromyographic monitoring of iliosacral screw insertion: a finite element model.
• Exenatide.
• Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
• Glucose tolerance testing for all?
• Long-term neurite orientation on astrocyte monolayers aligned by microtopography.
• Method of atrioventricular programming in atrial flutter in patients with biventricular pacemaker.
• Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier.
• Online hysterectomy support: characteristics of Website experiences.
• Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
• Predictors of alcohol use during the first year of college: implications for prevention.
• Review of Russian language studies on radionuclide behaviour in agricultural animals: part 2. Transfer to milk.
• Silicone augmentation of the lip.
• Surface proteins of gram-positive bacteria and how they get there.
• The Activity Inventory: an adaptive visual function questionnaire.
• The transfer of different forms of (35)S to goat milk.
• Toward the next generation of research into small area effects on health: a synthesis of multilevel investigations published since July 1998.
• Tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence.
• Unusual presentation of myelopathy in a previously healthy man.
• Who should be considered at risk for maltreating their children?